Administration Undermines Farmers and Rural Economies With Unjustifiable Renewable Fuel Standard Waivers

Aug 11 2019
Washington, D.C. (August 10, 2019) –The Biotechnology Innovation Organization (BIO) released the following statement on the administration’s decision to issue 31 small refinery exemptions under the Renewable Fuel Standard.

BIO Proposes Greater Public Access to Information on New Agricultural Biotechnology Products

Aug 5 2019
The Biotechnology Innovation Organization (BIO) today put forward a consumer-friendly proposal that would improve public access to information about new agricultural biotechnology products. Combined with a new science-based regulatory approach, BIO’s proposal will foster greater public confidence and support bringing new sustainable agricultural solutions to the market.

HHS Drug Importation Plan a “Misguided Attempt to Keep an Ill-Informed Campaign Promise”

Jul 31 2019
“There is simply no way to adopt an importation scheme that doesn’t jeopardize the health and well-being of America’s patients," BIO’s President and CEO Jim Greenwood said.

BIO Asia-Taiwan 2019 Showcased Biotech as the Region’s Next Growth Engine

Jul 29 2019
Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities

Senate Finance Drug Pricing Proposal Misses the Mark

Jul 23 2019
“While we’re pleased that the Senate Finance Committee proposal caps what beneficiaries have to pay out of pocket for medicines under Medicare Part D, it adopts a framework that punishes some of the most innovative biotech cures and transformative therapies." 

Increased Investment in Research for Debilitating Diseases is Focus of Newly Introduced Bill in Congress Today

Jul 23 2019
Legislation would significantly improve the ability of emerging biotechnology companies to focus their investor capital on science and biomedical innovation was introduced in the House of Representatives by Reps. Trey Hollingsworth (R-IN) and Ben McAdams (D-UT). The Fostering Innovation Act extends one vital JOBS Act provision – the temporary exemption from Section 404(b) of Sarbanes-Oxley (SOX) – for an additional five years for qualifying pre-revenue small businesses.

BIO World Congress Showcases Green Solutions to Address Global Challenges

Jul 11 2019
As presidential candidates trek across the Hawkeye State and campaign on addressing society’s most pressing challenges, biotech innovators wrapped up four days of showcasing the scientific solutions to climate change, hunger, pollution and energy security.

White House Deals Blow to Seniors, Withdraws Plan to Lower Out-of-Pocket Drug Costs

Jul 11 2019
BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers' rebates be passed along to seniors enrolled in the Medicare drug benefit program.

Bipartisan Bill Will Strengthen Patent Rights and Protect U.S. Leadership in Biotechnology Innovation

Jul 10 2019
Strong patent rights are essential to finance the revolution in biotechnology discoveries from the lab to the patient, farmer, and consumer

2020 Renewable Fuel Increase Could Be Welcome News for Advanced Biofuels

Jul 8 2019
The Biotechnology Innovation Organization (BIO) released the following statement on the U.S. Environmental Protection Agency’s (EPA) proposed Renewable Fuel Standard (RFS) volumes for 2020.